Slideshow – First Country Model Approach to Zero Leprosy: Nepal

A nurse at a local health post in southern Nepal chats with a team from the Global Partnership for Zero Leprosy and the National Leprosy Programme of Nepal. Nurses in posts like these provide on-going care for leprosy patients in their own communities.
A doctor reviews leprosy patient records at a health post in southern Nepal.
Doctors consult a patient about his medication regimen in a health post in southern Nepal. Leprosy patients take an antibiotic course called Multi Drug Therapy (MDT) to cure the disease.
Muti Drug Therapy (MDT) is made freely available to all leprosy patients around the world through a partnership between Novartis and the World Health Organization.
A doctor checks a woman’s hands for visible disability at a local health post in southern Nepal. This woman is receiving treatment for leprosy, but the disease was caught and treated early, so she is not suffering from nerve damage in her hands and other extremities.
Dermatologists test a man’s hands for visible impairment. This man was not diagnosed with leprosy quickly enough to prevent nerve damage in his hands, which has caused muscle paralysis, and he has trouble straightening his fingers during this test.
Doctors check a leprosy patient’s elbow for nerve damage.
Doctors check a leprosy patient’s hands for signs of disease progression and impairment.
A young woman named Mangu receives treatment for leprosy at her local health post in southern Nepal.
Once a month, Mangu visits the clinic for a refill of the antibiotics she's taking to treat the disease and to discuss her symptoms with the auxiliary health worker. The majority of leprosy patients in Nepal receive treatment at small local clinics like this one.

Courtesy of: Global Partnership for Zero Leprosy

On request by the Ministry of Health of Nepal, the Global Partnership for Zero Leprosy (GPZL) and the World Health Organization’s (WHO) Global Leprosy Programme conducted a two-week long country review in Nepal in July 2019. This review was conducted in close collaboration with the National Leprosy Program staff, local NGOs (including ILEP partners and organizations of persons affected), and WHO Nepal. The mission consisted of field visits and a stakeholder review meeting to take stock of the program’s current status and define key priorities for the program.

Based on findings from the field visits and stakeholder review meeting, a Zero Leprosy roadmap for Nepal was developed by a broad range of stakeholders that set 2030 targets and interim milestones for 2022 and 2025.

On 17th July, these findings and milestones were presented to the Minister of Health and other senior officials of the Ministry. These representatives from the ministry expressed appreciation for the review team and all participating partners for the clear results of the mission.

Additionally, the ministers promised to set in motion the abolishment of the only remaining law in Nepal that discriminates against persons affected by leprosy.

Findings of this first country model approach will be presented on the 10th of September during the International Leprosy Congress in Manila. The GPZL wants to sincerely thank the Nepal team for hosting the review team. Their support was excellent and of great importance.

If you are a national program manager and are interested in learning more about GPZL’s country model approach or requesting this support for your own country, please visit our Expression of Interest form.

Also see

The Partnership’s Mission to Nepal

A Leprosy Advocate, Who Was Once a Patient, Talks About Stigma, Empowerment, and Treatment


Global Partnership for Zero Leprosy

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on LinkedIn
Share on facebook
Share on twitter
Share on linkedin

Explore More Posts

Scroll to Top